A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)
Completed · Phase 1 · Has a placebo group
Conditions studied: Healthy
In brief
The goal of this trial is to learn about the safety of MK-1167 and if people tolerate it.
Key facts
- Study ID
- NCT07266818
- Run by
- Merck Sharp & Dohme LLC
- People needed
- 30
- Starts
- 2025-12-18
- Expected to finish
- 2026-04-09
- Last updated by the study team
- 2026-04-28
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.
Where it is running
- Hassman Research Institute Marlton Site ( Site 0001) — Marlton, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.